Showing results (81-90 of 140) with videos related to
Sort By:
Pageof 14
British Journal of Cancer|March 19, 2019
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistanceBen C Creelan, Jhanelle E Gray, Tawee Tanvetyanon, et al.Clinical Nuclear Medicine|January 29, 2013
Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsVirendra Kumar, Kavindra Nath, Claudia G Berman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancerGeorge Simon, Anupama Sharma, Xueli Li, et al.Leukemia & Lymphoma|November 21, 2008
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialSucha Nand, John Godwin, Scott Smith, et al.Case Reports in Transplantation|August 9, 2020
Kidney Transplantation for Erdheim-Chester DiseaseJongwon Yoo, Cynthia Gunsteen, Sima Patel, et al.American Journal of Hematology|June 2, 2005
Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibitionSerhan Alkan, Qin Huang, Melek Ergin, et al.Head & Neck|April 22, 2016
Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomasMatthew J Mifsud, Tawee Tanvetyanon, Judith C Mccaffrey, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancerLary A Robinson, Tawee Tanvetyanon, Deanna Grubbs, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinomaBen C Creelan, Scott Antonia, David Noyes, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancerGerold Bepler, K Eric Sommers, Alan Cantor, et al.Pageof 14